» Articles » PMID: 37250406

Molecular Analysis and Prenatal Diagnosis of Seven Chinese Families with Genetic Epilepsy

Overview
Journal Front Neurosci
Date 2023 May 30
PMID 37250406
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Genetic epilepsy is a large group of clinically and genetically heterogeneous neurological disorders characterized by recurrent seizures, which have a clear association with genetic defects. In this study, we have recruited seven families from China with neurodevelopmental abnormalities in which epilepsy was a predominant manifestation, aiming to elucidate the underlying causes and make a precise diagnosis for the cases.

Methods: Based on the molecular findings, we have associated the intragenic deletion in with the mutagenesis mechanism of -mediated genomic rearrangements for the first time and provided genetic counseling, medical suggestions, and prenatal diagnosis for the families. In conclusion, molecular diagnosis is crucial to obtain improved medical outcomes and recurrence risk evaluation for genetic epilepsy.

Results: A gross intragenic deletion detected in was investigated via gap-polymerase chain reaction (PCR), real-time quantitative PCR (qPCR), and mRNA sequence analysis. We identified 11 variants in seven genes (, and ) responsible for genetic epilepsy in the seven families, respectively. A total of six variants (c.1408T>G in , c.1994_1997del in , c.794G>A in , c.2453C>T in , and c.217dup and c.863+995_998+1480del in ) have not yet been reported to be associated with diseases and were all evaluated to be pathogenic or likely pathogenic according to the American College of Medical Genetics and Genomics (ACMG) guidelines.

Citing Articles

Setting the Stage for Treatment of Aminoacyl-tRNA Synthetase (ARS)1-Deficiencies: Phenotypic Characterization and a Review of Treatment Effects.

Hoytema van Konijnenburg E, Rohof J, Kok G, van Hasselt P, van Karnebeek C, Muffels I J Inherit Metab Dis. 2025; 48(2):e70017.

PMID: 40044141 PMC: 11882346. DOI: 10.1002/jimd.70017.


Case Report: A 3' splice site variation in exon 3 associated with idiopathic generalized epilepsy in a child.

Shi D, Li N, Fan C, Luo Q Front Genet. 2025; 15:1508922.

PMID: 39897619 PMC: 11782219. DOI: 10.3389/fgene.2024.1508922.


Congenital muscular dystrophies and myopathies: the leading cause of genetic muscular disorders in eleven Chinese families.

Mao B, Cai X, Lin N, Jiang Y, Hao N, Dai Y BMC Musculoskelet Disord. 2025; 26(1):51.

PMID: 39815277 PMC: 11734487. DOI: 10.1186/s12891-025-08289-5.

References
1.
Sharma S, Prasad A . Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches. Int J Mol Sci. 2017; 18(7). PMC: 5535877. DOI: 10.3390/ijms18071384. View

2.
Dunn P, Albury C, Maksemous N, Benton M, Sutherland H, Smith R . Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes. Front Genet. 2018; 9:20. PMC: 5808353. DOI: 10.3389/fgene.2018.00020. View

3.
Thurman D, Beghi E, Begley C, Berg A, Buchhalter J, Ding D . Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia. 2011; 52 Suppl 7:2-26. DOI: 10.1111/j.1528-1167.2011.03121.x. View

4.
. A roadmap for precision medicine in the epilepsies. Lancet Neurol. 2015; 14(12):1219-28. PMC: 4663979. DOI: 10.1016/S1474-4422(15)00199-4. View

5.
Baruffini E, Horvath R, Dallabona C, Czermin B, Lamantea E, Bindoff L . Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model. Mitochondrion. 2010; 11(1):182-90. DOI: 10.1016/j.mito.2010.09.007. View